ISNTD drug discovery and development: Conference

Date: 10 - 11 May 2018
Location: Institute of Child Health, London
 
Abstract deadline: Sunday 18th March 2018
Early bird registration deadline: 31st January 2018
 
At this turning point in terms of drug discovery & development for NTDs, the International Society for Neglected Tropical Diseases is presenting ISNTD d3 to address the past shortfalls in R&D productivity and drive the development of future paths towards successful gains in the control, treatment or evaluation of NTDs.
 
ISNTD d3 will bring togther experts from within drug discovery and clinical trials to drive the debate and foster new partnerships & alliances leading to tangible outcomes in terms of new therapies to combat these diseases.
 
ISNTD d3 also aims to accelerate the networking required for the development & distribution of new or improved drugs, vaccines, microbicides and diagnostics against the NTDs by bringing focus onto the phase II and III clinical trials taking place or set to take place potentially in affected countries.
 
The ISNTD is committed to the reality of the patients experiences and recognises the high co-endemicity and co-infections with other diseases including HIV, TB and malaria - therefore these are always an integral part of discussions within ISNTD conferences as crucial partners for NTD control.
 
For more information and to register, please click here

Reply